Home

Discours passé mouvement thermo sirna design Une planche trou patron

AGO-accessible anticancer siRNAs designed with synergistic miRNA-like  activity: Molecular Therapy - Nucleic Acids
AGO-accessible anticancer siRNAs designed with synergistic miRNA-like activity: Molecular Therapy - Nucleic Acids

Hairpin-like siRNA-Based Spherical Nucleic Acids | Journal of the American  Chemical Society
Hairpin-like siRNA-Based Spherical Nucleic Acids | Journal of the American Chemical Society

The workflow for functional siRNA prediction with a new design algorithm. |  Download Scientific Diagram
The workflow for functional siRNA prediction with a new design algorithm. | Download Scientific Diagram

Thermo Dharmacon RNAi Total Solution! - ㈜서린 > BRIC
Thermo Dharmacon RNAi Total Solution! - ㈜서린 > BRIC

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA  Conjugates: Molecular Therapy
Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates: Molecular Therapy

In Vivo RNAi | Thermo Fisher Scientific - JP
In Vivo RNAi | Thermo Fisher Scientific - JP

A Simple and Cost-Effective Approach for In Vitro Production of Sliced  siRNAs as Potent Triggers for RNAi: Molecular Therapy - Nucleic Acids
A Simple and Cost-Effective Approach for In Vitro Production of Sliced siRNAs as Potent Triggers for RNAi: Molecular Therapy - Nucleic Acids

Frontiers | Synthetic RNAs for Gene Regulation: Design Principles and  Computational Tools
Frontiers | Synthetic RNAs for Gene Regulation: Design Principles and Computational Tools

siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA  Interference in Response to 2′-OMe Modifications | ACS Omega
siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega

Ambion™ Silencer™ Pre-Designed siRNA, In Vivo: RNAi and RNA Reagents  Molecular Biology Reagents and Kits | Fisher Scientific
Ambion™ Silencer™ Pre-Designed siRNA, In Vivo: RNAi and RNA Reagents Molecular Biology Reagents and Kits | Fisher Scientific

A protocol for designing siRNAs with high functionality and specificity |  Nature Protocols
A protocol for designing siRNAs with high functionality and specificity | Nature Protocols

Treatment of Melanoma by Nano-conjugate-Delivered Wee1 siRNA | Molecular  Pharmaceutics
Treatment of Melanoma by Nano-conjugate-Delivered Wee1 siRNA | Molecular Pharmaceutics

Pharmaceutics | Free Full-Text | Analyzing siRNA Concentration,  Complexation and Stability in Cationic Dendriplexes by Stem-Loop Reverse  Transcription-qPCR
Pharmaceutics | Free Full-Text | Analyzing siRNA Concentration, Complexation and Stability in Cationic Dendriplexes by Stem-Loop Reverse Transcription-qPCR

Design of a platform technology for systemic delivery of siRNA to tumours  using rolling circle transcription | Nature Communications
Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription | Nature Communications

Pharmaceuticals | Free Full-Text | Design of siRNA Therapeutics from the  Molecular Scale
Pharmaceuticals | Free Full-Text | Design of siRNA Therapeutics from the Molecular Scale

Precise and efficient siRNA design: a key point in competent gene silencing  | Cancer Gene Therapy
Precise and efficient siRNA design: a key point in competent gene silencing | Cancer Gene Therapy

IJMS | Free Full-Text | Structural Modifications of siRNA Improve Its  Performance In Vivo
IJMS | Free Full-Text | Structural Modifications of siRNA Improve Its Performance In Vivo

siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA  Interference in Response to 2′-OMe Modifications | ACS Omega
siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega

Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA  Molecules: From Bench Tool to the Refined Drug
Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug

Stealth RNAi™ siRNA Negative Control, Med GC
Stealth RNAi™ siRNA Negative Control, Med GC

Advancing peptide siRNA-carrier designs through L/D-amino acid  stereochemical modifications to enhance gene silencing: Molecular Therapy -  Nucleic Acids
Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencing: Molecular Therapy - Nucleic Acids

IJMS | Free Full-Text | Investigation of Strand-Selective Interaction of  SNA-Modified siRNA with AGO2-MID
IJMS | Free Full-Text | Investigation of Strand-Selective Interaction of SNA-Modified siRNA with AGO2-MID

siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA  Interference in Response to 2′-OMe Modifications | ACS Omega
siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega

Programmable siRNA pro-drugs that activate RNAi activity in response to  specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids
Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids